financetom
Business
financetom
/
Business
/
Boeing Deliveries, Orders Tumble Year Over Year in May; Shares Fall
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Boeing Deliveries, Orders Tumble Year Over Year in May; Shares Fall
Jun 11, 2024 11:05 AM

01:37 PM EDT, 06/11/2024 (MT Newswires) -- Boeing ( BA ) on Tuesday posted lower deliveries and orders for May from a year earlier, sending the plane maker's stock slumping.

The company delivered 24 jets last month, including 19 737 Max aircraft. May's total deliveries matched the previous month's tally, but were down from 50 a year earlier, according to data posted on the company's website.

Boeing ( BA ) booked four gross orders last month, down from seven in April and 69 a year earlier. The company didn't book any orders for its best-selling 737 Max jet for the second consecutive month, the data showed.

Boeing ( BA ) shares were down 2.9% in afternoon trading.

In April, the company logged an unexpected narrower first-quarter loss, while revenue declined annually. The company said at the time it reduced output of its 737 program to below 38 planes per month to implement quality management system improvements and ease traveled work within its factory and supply chain.

In January, the US Federal Aviation Administration launched an investigation into Boeing ( BA ) after a 737 Max 9 operated by Alaska Air ( ALK ) suffered a mid-air panel blowout.

So far in 2024, Boeing ( BA ) has delivered 131 jetliners and booked 142 gross orders. As of May 31, it had 6,188 unfilled orders, the data showed.

Earlier this month, Boeing's ( BA ) European rival Airbus said it delivered 53 aircraft in May, bringing its 2024 total so far to 256, while its gross orders reached 27 last month.

The companies' order activity is likely to get a boost from next month's Farnborough Airshow, Truist Securities said in a Tuesday note. However, "weak" original equipment manufacturer delivery activity is expected to persist in the coming months, the brokerage said. "The weak deliveries, specifically on the narrow-body side, will likely to be an area of investor focus into (the second-quarter) earnings season."

Price: 184.57, Change: -5.55, Percent Change: -2.92

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Lazard Posts Higher Preliminary Assets Under Management in April From a Month Ago
Lazard Posts Higher Preliminary Assets Under Management in April From a Month Ago
May 26, 2025
08:23 AM EDT, 05/12/2025 (MT Newswires) -- Lazard ( LAZ ) reported preliminary assets under management Monday of $231.41 billion as of April 30, up from $227.43 billion a month earlier. The company reported foreign exchange appreciation of $5.10 billion, market depreciation of $900 million, and net outflows of $200 million for April. ...
Quantum Biopharma Completes 90-Day Dosing Studies for Lucid-MS
Quantum Biopharma Completes 90-Day Dosing Studies for Lucid-MS
May 26, 2025
08:23 AM EDT, 05/12/2025 (MT Newswires) -- Quantum BioPharma ( QNTM ) , up nearly 2% in U.S. pre-market trade, on Monday said dosing has been completed in 90-day oral toxicity and toxicokinetic studies for Lucid-21-302 (Lucid-MS) for Multiple Sclerosis (MS). These studies were commissioned to provide data to support an investigation new drug (IND) application with the U.S. FDA....
Insurance broker Hub International secures $29 billion valuation in $1.6 billion investment deal
Insurance broker Hub International secures $29 billion valuation in $1.6 billion investment deal
May 26, 2025
(Reuters) - Insurance broker Hub International said on Monday it has secured a $29 billion valuation in a minority investment transaction of about $1.6 billion. The investment is led by funds and accounts advised by T. Rowe Price Investment Management, Alpha Wave Global, and Temasek, along with participation from other investors. The company's valuation is an increase from $23 billion...
Copyright 2023-2026 - www.financetom.com All Rights Reserved